Dr. DeVita is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
130 East 77th Street
5th Floor
New York, NY 10075Phone+1 212-434-6800Fax+1 212-734-2133
Education & Training
- Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalFellowship, Nephrology, 1987 - 1989
- Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalResidency, Internal Medicine, 1984 - 1987
- Georgetown University School of MedicineClass of 1984
Certifications & Licensure
- NJ State Medical License 1989 - 2025
- NY State Medical License 1985 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- New York Magazine: Top Doctors Castle Connolly, 2014
- Top Doctors: New York Metro Area Castle Connolly, 2009-2014
- Top MD Consumers Checkbook
- Join now to see all
Publications & Presentations
PubMed
- 64 citationsA review of the nonpressor and nonantidiuretic actions of the hormone vasopressin.Gaurang Mavani, Maria V. DeVita, Michael F. Michelis
Frontiers in Medicine. 2015-03-24 - 42 citationsImpact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease.Jordan L. Rosenstock, Emmanuelle Gilles, Ari B. Geller, Georgia Panagopoulos, Staicy Mathew
International Urology and Nephrology. 2010-07-04 - 111 citationsHistopathologic and Ultrastructural Findings in Postmortem Kidney Biopsy Material in 12 Patients with AKI and COVID-19.Pouneh Golmai, Christopher P. Larsen, Maria V. DeVita, Samuel J Wahl, Astrid Weins
Journal of the American Society of Nephrology. 2020-07-16
Press Mentions
- Nuwellis Announces Data Demonstrating Statistically Superior Clinical Benefit of Aquadex Therapy in Reducing Heart Failure Events and Mortality at the 2022 HFSA MeetingOctober 3rd, 2022
- Nuwellis Announces the Activation of New Sites for Its Pivotal REVERSE-HF TrialSeptember 27th, 2022
- Nuwellis Announces First Patient Enrolled in Its Pivotal Trial REVERSE-HFJune 29th, 2022
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: